Carlo Albera - Concepedia

Author

Carlo Albera

Also Known As

ALBERA, Carlo, C Albera, C. Albera, C. Vancheri, C., Albera, CARLO ALBERA, Carlo ALBERA, Carlo Albera, Carlos Albera, Claudia Albera

130

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Turin Ruhrlandklinik University of Colorado Denver Ospedale San Luigi Gonzaga Roche (Switzerland)

About

Carlo Albera is an author at University of Turin specializing in medicine, pathology, and lung inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	891
2	Business	1	1	59
3	Health Sciences	1	1	19
4	Management	1	1	59
5	Natural Sciences	1	1	10

Carlo Albera

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement Robert P. Baughman, Marjolein Drent, Mani S. Kavuru, American Journal of Respiratory and Critical Care Medicine	2006	702
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial Luca Richeldi, Evans R. Fernández Pérez, Ulrich Costabel, The Lancet Respiratory Medicine FibrosisAntifibrotic TherapyInflammatory Lung DiseaseAdvanced Lung DiseaseLung Inflammation	2019	275
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial Dinesh Khanna, Carlo Albera, Aryeh Fischer, The Journal of Rheumatology	2016	262
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis Marc A. Judson, Robert P. Baughman, Ulrich Costabel, European Respiratory Journal Clinical ImmunologyMajor Secondary End-pointsInflammatory Lung DiseaseLung InflammationImmunodeficiencies	2014	210
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial Jürgen Behr, Elisabeth Bendstrup, Bruno Crestani, The Lancet Respiratory Medicine Idiopathic Pulmonary FibrosisPharmacologyPulmonary PharmacologyPulmonary FibrosisPulmonary Medicine	2016	162
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan, European Respiratory Journal	2016	158
An Open-Label Study of the Long-Term Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (RECAP) Ulrich Costabel, Carlo Albera, Lisa Lancaster, Respiration	2017	147
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Vincent Cottin, Dirk Koschel, Andreas Günther, ERJ Open Research	2018	111
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment Steven D. Nathan, Ulrich Costabel, Carlo Albera, Respiratory Medicine	2019	75
SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience Filippo Patrucco, Carlo Albera, Michela Bellocchia, Respiration	2020	68

Page 1